States Wade into Disclosure Rules on Biosimilars

As the Obama administration continues work on an approval process for biosimilars, physician organizations have advocated that any state legislation on the issue contains language that adequately notifies prescribing doctors in the event an original biologic is substituted with a biosimilar product... Read More

California Senate Requires Larger Print for Drug Labels

Ever squinted to read the directions on a medicine bottle but couldn’t make out the small print? California lawmakers have the prescription to solve that problem. The state Senate has approved legislation requiring pharmacists to print specific, important information on prescription labels in at least 12-point type... Read More